Work

Patient-specific tumor-informed circulating tumor DNA (ctDNA) analysis for molecular residual disease (MRD) detection in surgical patients with stage I-IV colorectal cancer (CRC).

Year: 2023

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2023.41.4_suppl.213

Authors: Di Cao, Fu-Long Wang, Cong Li, Rong-Xin Zhang, Xiao-Jun Wu, Liren Li, Zhen-Hai Lu, Zhi-Zhong Pan, Jun-zhong Lin, Miaoqing Wu, Yifan Liu, Guangzhao Lv, Min Li, Chenyang Wang, Xi Li, Gong Chen

Institutions: Sun Yat-sen University Cancer Center, Burning Rock Biotech (China)

Language: English

Topic: Cancer Genomics and Diagnostics

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4317890299

Cites:

Cited by: 4

Related to: 10